Results 21 to 30 of about 56,192 (268)

Influence of peptidylarginine deiminase type 4 genotype and shared epitope on clinical characteristics and autoantibody profile of rheumatoid arthritis. [PDF]

open access: yes, 2009
Background: Recent evidence suggests that distinction of subsets of rheumatoid arthritis (RA) depending on anticyclic citrullinated peptide antibody (anti-CCP) status may be helpful in distinguishing distinct aetiopathologies and in predicting the ...
Burmester, G.R.   +7 more
core   +1 more source

Nonsystemic vasculitic neuropathy

open access: yesMedical Journal of Dr. D.Y. Patil Vidyapeeth, 2020
A 21-year-old female born of nonconsanguineous marriage presented with gradually progressive quadriplegia for 3 years. Weakness was distal more than proximal, with wasting. She also had moderate pain in extremities.
Shalesh Rohatgi   +2 more
doaj   +1 more source

Inflammatory bowel disease-specific autoantibodies in HLA-B27-associated spondyloarthropathies: Increased prevalence of ASCA and pANCA [PDF]

open access: yes, 2004
Aims: An association between inflammatory bowel disease (IBD) and spondyloarthropathies (SpA) has repeatedly been reported. The aim of the present study was to investigate whether serologic markers of IBD, e. g.
Brumberger, V.   +7 more
core   +1 more source

Lupus-like nephritis with positive anti-neutrophil cytoplasmic antibodies and negative antinuclear antibodies

open access: yesBrazilian Journal of Nephrology, 2020
Antineutrophil cytoplasmic antibodies (ANCAs) are associated with small vessel vasculitis but their prevalence is not rare in other immune diseases.
Joana Eugénio Santos   +6 more
doaj   +2 more sources

Could Antinuclear Antibody Positivity Be a Factor Affecting Treatment Response in Immune Thrombocytopenia Patients on Eltrombopag?

open access: yesTurkish Journal of Hematology, 2022
Objective: Eltrombopag remains a prominent option in the treatment of steroid-dependent or steroid-refractory immune thrombocytopenia (ITP) patients. Unfortunately, not all patients respond to eltrombopag.
Mehmet Baysal   +4 more
doaj   +1 more source

Applying Choosing Wisely: Antinuclear Antibody (ANA) and Sub-Serology Testing in a Safety Net Hospital System. [PDF]

open access: yes, 2015
ObjectiveIn 2013, the American College of Rheumatology (ACR) participated in the Choosing Wisely campaign and devised a recommendation to avoid testing antinuclear antibody (ANA) subserologies without a positive ANA and clinical suspicion of disease. The
Davis, Lisa Anne   +7 more
core   +2 more sources

Antinuclear Antibodies in Patients with Psoriatic Arthritis Treated or Not with Biologics. [PDF]

open access: yesPLoS ONE, 2015
With the emergence of biotherapies, accurate diagnosis in early arthritis is needed. At this time, there is no biological marker of psoriatic arthritis.To test whether antinuclear antibodies (ANA) can be used as a diagnostic tool in psoriatic arthritis ...
Florent Silvy   +8 more
doaj   +1 more source

Antinuclear Antibodies: A demographic profile from a Tertiary Healthcare Centre of Delhi

open access: yesSVU - International Journal of Medical Sciences, 2023
Background: Anti-nuclear autoantibodies (ANA), have explicitly been linked to immune complex-mediated autoimmune diseases. Detection and quantitation of autoantibodies are therefore crucial in the diagnosis and treatment.
Krishna Sarkar   +3 more
doaj   +1 more source

Immune myopathies with perimysial pathology: Clinical and laboratory features [PDF]

open access: yes, 2018
ObjectiveImmune myopathies with perimysial pathology (IMPP) have a combination of damage to perimysial connective tissue and muscle fiber necrosis, more prominent near the perimysium.
Bucelli, Robert C, Pestronk, Alan
core   +2 more sources

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

open access: yes, 2022
Hepatology, EarlyView.
Robert J. Fontana   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy